Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.3, Iss.6, 2002-01, pp. : 421-425
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ximelagatran: Exanta, H 376, H 376/95, H 37695
Drugs in R&D, Vol. 3, Iss. 6, 2002-01 ,pp. :
Access to resources
Recommend
Liver AE leads to withdrawal of Exanta
Reactions Weekly, Vol. 1, Iss. 1089, 2006-01 ,pp. :
Pharmacokinetics of melagatran unaffected by aspirin
Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. :
Ximelagatran + melagatran superior against VTE
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Ximelagatran, melagatran dosage in severe renal impairment
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :